Finland· FI-REL-REL5104

Navane

A tiotixene product, registered in Finland by Pfizer Service Company BVBA.

ATC N05AF04

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNavaneATCN05AF04REGISTER NO.FI-REL-REL5104PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Pfizer Service Company BVBA
Country
Finland (FI)
ATC code
N05AF04
ATC class
Tiotixene
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under N05AF04

Tiotixene, as other registers publish it.

All tiotixene products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1be1577a-899d-40dc-8a59-d41244de6483
GET /v1/drugs/1be1577a-899d-40dc-8a59-d41244de6483?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "30",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "mg",
  "strength": "10 mg",
  "atc_label": "tiotikseeni",
  "ma_number": "5168",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL5104",
  "authorised_at": "1968-01-17"
}

See everything about tiotixene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.